CNS Pharmaceuticals Inc.

NASDAQ: CNSP · Real-Time Price · USD
1.04
0.03 (2.97%)
At close: Jun 06, 2025, 3:58 PM
1.04
0.01%
After-hours: Jun 06, 2025, 05:46 PM EDT
2.97%
Bid 1.01
Market Cap 5.68M
Revenue (ttm) 3.14K
Net Income (ttm) -15.61M
EPS (ttm) -924.6
PE Ratio (ttm) n/a
Forward PE -0.77
Analyst Buy
Ask 1.04
Volume 196,668
Avg. Volume (20D) 1,720,995
Open 1.02
Previous Close 1.01
Day's Range 1.01 - 1.06
52-Week Range 0.77 - 414.00
Beta 0.78

About CNSP

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNSP
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CNSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+12.4%
CNS Pharmaceuticals shares are trading higher afte... Unlock content with Pro Subscription
2 months ago
-51.78%
CNS Pharmaceuticals shares are trading lower after the company announced the primary analysis of its clinical trial evaluating Berubicin for the treatment of recurrent or progressive Glioblastoma Multiforme did not demonstrate statistically significant superiority in overall survival, the primary endpoint.